The Novo Nordisk Foundation has allocated up to €736 million (DKK 5.5 billion) to BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activities into new strategic areas and geographies, and support…
Continue reading...